What the analyst said
UBS analyst Timothy Arcuri lowered the price target on NVIDIA (NASDAQ: NVDA) to $220 (from $240) while maintaining a Buy rating.
“FQ3 results were even better than normal, while guidance for both FQ4 (Jan) and the slight walk-up of C2027 played out exactly as we previewed and better than some investors feared given concerns around a big miss or rescindment of C2027 guidance.
Put simply, the guidance raise and tone on the call presented the symbolic show of strength that we previewed and the confidence in C2027 remains very high – as evidenced by adding >$100B to supply commits for C2027 delivery and now seemingly having the year fully covered for COGS.
This should help a little in the near term as some investors have been worried about C2027 cuts, but our view has always been that this is more about how much things decelerate in C2028. On one hand, it would have been nice to see C2028 supply commits increase significantly as well, but on the other hand, we think there is a very real risk that NVDA becomes beholden to these purchase commitments and has to keep throwing money at its customers to drive revenue.
On top of broader concerns, talent retention given recent management changes might also be a legitimate concern here. We called out NVDA’s support for the ecosystem and neoclouds in particular (a very important core customer base for NVDA) as something to watch, and while the company remains committed, the language to us sounded more measured (“disciplined and selective”).
Further, the company’s commentary on share repo supports a step up to ~$40-50B/Q, and this number should continue to move higher.
Lastly, the company announced that the 10-Q will be filed “in the coming weeks” – later than usual. When queried on our callback, management indicated this was related to the ongoing investigation and whether any additional risk factors would need to be added to the filing.
Net, we make only minor tweaks to C2027, trim C2028 a bit more (now up <10% Y/Y) with EPS now ~$18.80 and take a view that C2029 also doesn’t grow, but doesn’t decline either.”
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.
This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.
Where the price stands
NVDA trades at $149. The 38 analysts who set a target in the last 3 months range from $135 to $350, with a median of $228. This $220 target is 3% below the median.
12-month window: day 1 of 365, closes on November 18, 2027.
Track record
This callOpen: NVDA has not reached $220 yet. This 12-month target is scored on November 18, 2027.
Firm track recordUBS: 83% of its 58 targets at least a year old were reached within 12 months (#9 of 29 firms); on NVIDIA, 6 of 6. Accuracy ranking →
UBS on NVIDIA
UBS price targets on NVIDIA
8 calls from May 11, 2026 to November 18, 2026. The target went from $245 to $220 (−10%). The rating stayed Buy.
- November 18, 2026 This noteTarget cut from $240 (−8%)Buy$220
- November 16, 2026Target cut from $300 (−20%)Buy$240
- November 12, 2026Kept the $300 targetBuy$300
- October 9, 2026Kept the $300 targetBuy$300
- August 27, 2026Target raised from $280 (+7%)Buy$300
- August 14, 2026Target raised from $275 (+2%)Buy$280
- May 14, 2026Target raised from $245 (+12%)Buy$275
- May 11, 2026Earliest call shownBuy$245





